Astrazeneca stock

astrazeneca stock

What will AstraZenecas stock price be worth in the next year?

15 brokerages have issued twelve-month price objectives for AstraZenecas shares. Their forecasts range from $69.00 to $175.00. On average, they expect AstraZenecas stock price to reach $122.00 in the next year. This suggests a possible upside of 108.1% from the stocks current price.

What is the dividend policy of AstraZeneca Pharma India?

An equity Interim dividend of Rs 2 per share was declared by Astrazeneca Pharma India on 09 Aug 2021. So, company has declared a dividend of 100% on face value of Rs 2 per share.

Where does the majority of AstraZenecas sales come from?

The majority of sales come from international markets with the United States representing close to one third of its revenue. Analyst Report: AstraZeneca PLC A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999.

What does AstraZeneca plc do?

Sign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeats FREE daily newsletter. AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products.

What has happened to the AstraZeneca share price in 2020?

The AstraZeneca share price has been on a rollercoaster in 2020. The stock started the year at £76.60 per share, fell to £62.21 in March during the broader stock market sell-off, then rallied to an all-time high of £93.20 in July as investors anticipated positive trial results.

What are analysts forecasts for AstraZenecas stock?

18 equities research analysts have issued 12 month price objectives for AstraZenecas stock. Their forecasts range from $40.73 to $50.00. On average, they anticipate AstraZenecas share price to reach $46.12 in the next year.

What is AstraZenecas stock symbol?

What is AstraZenecas stock symbol? AstraZeneca trades on the NASDAQ under the ticker symbol AZN. Who are AstraZenecas major shareholders?

Is AstraZenecas PE ratio too expensive?

Earnings for AstraZeneca are expected to grow by 34.09% in the coming year, from $2.64 to $3.54 per share. The P/E ratio of AstraZeneca is 40.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.01.

What are AstraZeneca’s biggest products?

AstraZeneca is a global biopharmaceutical company with several leading pharmaceutical products. As of 2020, AstraZeneca’s top pharmaceutical product by revenue was Tagrisso, a medication used in the treatment of non-small-cell lung carcinomas. During that year, Tagrisso generated nearly 4.3 billion U.S. dollars in revenue for the company.

How much did AstraZeneca’s sales grow in 2020?

AstraZeneca said Thursday its product sales grew by 10% in 2020, a year in which the drugmaker garnered attention for its work developing a coronavirus vaccine.. The Anglo-Swedish pharmaceutical giant reported product sales totaling $25.8 billion for the year.

Is AstraZeneca plc a good company?

This statistic shows the revenue of pharmaceutical company AstraZeneca from 2006 to 2021. AstraZeneca plc is one of the top 15 pharmaceutical companies worldwide (based on Rx drug revenue).

What does AstraZeneca do for a living?

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory.

Postagens relacionadas: